Abstract:Background: Glomerular disease, often characterized by podocyte injury and proteinuria, can lead to chronic kidney disease and end stage kidney disease. We hypothesized that the glomerular pathophysiology is associated with alternative mRNA processing, such as alternative splicing (AS) and polyadenylation (APA), of glomerular genes and especially of critical podocyte, slit diaphragm and matrix genes that regulate the glomerular filtration barrier. Methods: Glomerular damage, accompanied with proteinuria, hypoalbuminemia and hypercholesterolemia was induced by puromycin aminonucleoside (PAN) or adriamycin (ADR) to mimic human minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS), respectively. Glomerular RNA-seq analyses was performed followed by JunctionSeq and APATrap bioinformatics analyses to detect AS and APA events, respectively. Novel splice sites and poly(A) usage sites and differences in alternatively spliced and polyadenylated isoforms were queried in JunctionSeq and APATrap pipelines. Results: Altered glomerular mRNA processing by AS/APA was identified in 136/71 and 1875/746 genes in MCD and FSGS models, respectively. Transcript annotation and prioritization of significant AS and APA identified key events in genes with novel and established roles that cause disruption in the glomerular filtration barrier. These events localized in the regions of slit diaphragm (NPHS1, NPHS2, NEPH1, ZO1, ITM2B), glomerular basement membrane (COL4A3/4/5, LAMB2, LAMA5), podocyte mitochondria (COQ2), podocyte membrane (PODXL) and endothelial cells (INF2). Concomitantly, numerous polyadenylation and splicing factors which could serve as potential trans- factors that lead to AS and APA, were dysregulated in these two models of glomerular nephropathies. Additionally, beneficial proteinuria reducing treatment modalities, pioglitazone and GQ16 reversed many of these AS and APA events. Moreover, suggestive GWAS SNPs were identified in many of these genes from human nephrotic syndrome database, which could potentially serve as cis- factors that lead to AS and APA, and downstream functional effects. Conclusion: Findings from our studies shed light on a new landscape of research in glomerular pathophysiology, i.e., AS and APA of glomerular genes, many of which are crucial determinants of podocyte structure and function, slit diaphragm complex, and glomerular basement membrane. These findings present new implications for improved mechanistic understanding of glomerular disease and development of novel therapeutic intervention strategies.

Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Genetic Reprogramming with Stem Cells Regenerates Glomerular Epithelial Podocytes in Alport Syndrome

Accelerated Podocyte Detachment and Progressive Podocyte Loss from Glomeruli with Age in Alport Syndrome.

Alternative mRNA Splicing and Polyadenylation Events are Synchronous with Podocyte Injury and Slit Diaphragm Dysregulation in Glomerular Disease Models

Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis

Establishment of Microrna, Transcript and Protein Regulatory Networks in Alport Syndrome Induced Pluripotent Stem Cells

Tauroursodeoxycholic Acid Ameliorates Renal Injury Induced by COL4A3 Mutation

Pharmacological approach and diagnosis for Alport syndrome

Endothelial Mitochondrial Oxidative Stress Determines Podocyte Depletion in Segmental Glomerulosclerosis.

Endoplasmic Reticulum Stress and Proteasome Pathway Involvement in Human Podocyte Injury with a Truncated COL4A3 Mutation

Endoplasmic Reticulum Stress Activation in Alport Syndrome Varies Between Genotype and Cell Type

Alport Syndrome: a Unified Classification of Genetic Disorders of Collagen IV Alpha 345: a Position Paper of the Alport Syndrome Classification Working Group

Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.

Novel Therapies for Alport Syndrome

A Novel Deep Learning Approach for Analyzing Glomerular Basement Membrane Lesions in a Mouse Model of X-Linked Alport Syndrome

Alport syndrome and Alport kidney diseases – elucidating the disease spectrum

Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments

Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience

Chemical chaperones to the rescue of Alport syndrome?

Determination of the Pathogenicity of a Novel COL4A5 Missense Variant by CRISPR-Cas9 in Kidney Podocytes.